Scuderi Carla E, Parker Suzanne L, Jacks Margaret, John George T, McWhinney Brett, Ungerer Jacobus, Mallett Andrew J, Healy Helen G, Roberts Jason A, Staatz Christine E
Kidney Health Service, Metro North Hospital and Health Service, Brisbane, Australia.
School of Pharmacy, University of Queensland, Brisbane, Australia.
Kidney Med. 2023 Feb 4;5(4):100610. doi: 10.1016/j.xkme.2023.100610. eCollection 2023 Apr.
RATIONALE & OBJECTIVE: Kidney transplant recipients require frequent venipunctures. Microsampling methods that use a finger-prick draw of capillary blood, like volumetric absorptive microsamplers (VAMS), have the potential to reduce the pain, inconvenience, and volume of blood loss associated with venipuncture. This study aimed to provide diagnostic accuracy using VAMS for measurement of tacrolimus and creatinine compared to gold standard venous blood in adult kidney transplant recipients.
Diagnostic test study. Prospective blood samples for measurement of tacrolimus and creatinine were collected using Mitra VAMS and venipuncture immediately before and 2 hours after tacrolimus dosing.
SETTING & PARTICIPANTS: A convenience sample of 40 adult kidney transplant participants in the outpatient setting.
Method comparison was assessed by Passing-Bablok regression and Bland-Altman analysis. The predictive performance of VAMS measurement compared to venipuncture was also assessed through estimation of the median prediction error and median absolute percentage prediction error.
A total of 74 tacrolimus samples and 70 creatinine samples were analyzed from 40 participants. Passing-Bablok regression showed a systematic difference between VAMS and venipuncture when measuring tacrolimus and creatinine with a slope of 1.08 (95% CI, 1.03-1.13) and a slope of 0.65 (95% CI, 0.6-0.7), respectively. These values were then corrected for the systematic difference. When used for Bland-Altman analysis, corrected values of tacrolimus and creatinine showed a bias of -0.1 μg/L and 0.04 mg/dL, respectively. Tacrolimus (corrected) and creatinine (corrected) microsampling values when compared to corresponding venipuncture values met median prediction error and median absolute percentage prediction error predefined acceptability limits of <15%.
This study was conducted in a controlled environment using a trained nurse to collect VAMS samples.
In this study, VAMS was used to reliably measured tacrolimus and creatinine. This represents a clear opportunity for more frequent and less invasive sampling for patients.
肾移植受者需要频繁进行静脉穿刺。微量采样方法,如使用手指针刺采集毛细血管血的容积吸收性微量采样器(VAMS),有可能减少与静脉穿刺相关的疼痛、不便和失血量。本研究旨在比较成人肾移植受者使用VAMS测量他克莫司和肌酐与金标准静脉血相比的诊断准确性。
诊断试验研究。在他克莫司给药前及给药后2小时,立即使用Mitra VAMS和静脉穿刺采集用于测量他克莫司和肌酐的前瞻性血样。
门诊环境中40名成年肾移植参与者的便利样本。
通过Passing-Bablok回归和Bland-Altman分析评估方法比较。还通过估计中位预测误差和中位绝对百分比预测误差来评估VAMS测量与静脉穿刺相比的预测性能。
对40名参与者的74份他克莫司样本和70份肌酐样本进行了分析。Passing-Bablok回归显示,在测量他克莫司和肌酐时,VAMS与静脉穿刺之间存在系统差异,斜率分别为1.08(95%CI,1.03 - 1.13)和0.65(95%CI,0.6 - 0.7)。然后对这些值进行系统差异校正。用于Bland-Altman分析时,校正后的他克莫司和肌酐值的偏差分别为-0.1μg/L和0.04mg/dL。与相应静脉穿刺值相比,他克莫司(校正后)和肌酐(校正后)的微量采样值符合中位预测误差和中位绝对百分比预测误差预先定义的<15%的可接受限度。
本研究在受控环境中进行,由经过培训的护士采集VAMS样本。
在本研究中,VAMS被用于可靠地测量他克莫司和肌酐。这为患者进行更频繁、侵入性更小的采样提供了明显机会。